Psychopharmacology of Neurologic Disease, Volume 165 in the Handbook of Clinical Neurology series, provides clinicians with an up-to-date, critical review of the best approaches to treatment of neurologic disease as discussed by experienced clinical investigators. The book is organized into sections on dementia, delirium, movement disorders, hereditary degenerative disease, epilepsy and psychogenic seizures, brain vascular disease, pseudobulbar affect, traumatic brain injury, neuro-oncology, multiple sclerosis and other demyelinating disorders, chronic fatigue syndrome/fibromyalgia, pain, headache, sleep disorders, autoimmune encephalitis/anti- NMDA encephalitis, functional sensory neurologic symptom disorders and neurodevelopmental disorders.
Each of these diagnostic categories has a significant incidence of behavioral symptomatology that is secondary to the neurologic diagnosis that can serve to complicate other therapeutic interventions, alter the course of illness, and cause distress in patients and family caregivers.
- Provides a systematic, evidence-based compendium of best practices in the treatment of behavioral symptomatology relating to neurologic conditions
- Integrates state-of-the-art approaches in treating all behavioral symptomatology across all major neurologic disorders
- Explores psychopharmacological intervention, non-pharmacological strategies, behavioral symptomatology, and therapeutic interventions
- Series: Handbook of Clinical Neurology Revised Series (Book 164)
- Hardcover: 468 pages
- Publisher: Elsevier Science Ltd; 1 edition (December 6, 2019)
- Language: English
- ISBN-10: 0444640126
- ISBN-13: 978-0444640123
- Product Dimensions: 8.5 x 10.9 inches